Accenture assists in Stanford's efforts to go paperless

Jeff Byers | | Health Exec | Economics
Accenture has landed a seven-year contract with Stanford Hospital & Clinics, part of the Stanford University Medical Clinic in Stanford, Calif., for a connected health technology initiative.

Under the agreement, Accenture will work with Stanford to deploy new capabilities, including business intelligence, health analytics tools and patient-centered technology. Accenture stated the company will assume certain operational and administrative responsibilities for Stanford’s IT environment.

Stanford will migrate to Accenture’s virtualization offering, according to the Chicago-headquartered company, which added that the firm will manage applications and infrastructure including applicable data centers, network, help desks and device support.

Jeff Byers

Related Content

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward
UnitedHealth pushes back against shareholder transparency proposal
Thousands of staff cut from federal health agencies, including CDC and VA
Nonprofit academic hospital receives criticism after running Super Bowl ad
HeartBeam raising $10M for FDA-cleared health tech with public offering

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”